Kamoshida G, Yamada N, Nakamura T, Yamaguchi D, Kai D, Yamashita M
Microbiol Spectr. 2022; 10(5):e0192822.
PMID: 36173297
PMC: 9602988.
DOI: 10.1128/spectrum.01928-22.
Wijers C, Pham L, Menon S, Boyd K, Noel H, Skaar E
Infect Immun. 2021; 89(12):e0045421.
PMID: 34460288
PMC: 8594612.
DOI: 10.1128/IAI.00454-21.
Hong Y, Lee J, Ko K
J Microbiol. 2018; 56(6):435-440.
PMID: 29858832
DOI: 10.1007/s12275-018-7449-0.
Uppuluri P, Lin L, Alqarihi A, Luo G, Youssef E, Alkhazraji S
PLoS Pathog. 2018; 14(5):e1007056.
PMID: 29746596
PMC: 5963808.
DOI: 10.1371/journal.ppat.1007056.
Farshadzadeh Z, Taheri B, Rahimi S, Shoja S, Pourhajibagher M, Haghighi M
Front Microbiol. 2018; 9:153.
PMID: 29483899
PMC: 5816052.
DOI: 10.3389/fmicb.2018.00153.
A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii.
Boll J, Crofts A, Peters K, Cattoir V, Vollmer W, Davies B
Proc Natl Acad Sci U S A. 2016; 113(41):E6228-E6237.
PMID: 27681618
PMC: 5068286.
DOI: 10.1073/pnas.1611594113.
Acinetobacter Infections among Adult Patients in Qatar: A 2-Year Hospital-Based Study.
Al Samawi M, Khan F, Eldeeb Y, Almaslamani M, Alkhal A, Alsoub H
Can J Infect Dis Med Microbiol. 2016; 2016:6873689.
PMID: 27433169
PMC: 4940524.
DOI: 10.1155/2016/6873689.
Head-to-Head Comparison of Two Multi-Locus Sequence Typing (MLST) Schemes for Characterization of Acinetobacter baumannii Outbreak and Sporadic Isolates.
Tomaschek F, Higgins P, Stefanik D, Wisplinghoff H, Seifert H
PLoS One. 2016; 11(4):e0153014.
PMID: 27071077
PMC: 4829225.
DOI: 10.1371/journal.pone.0153014.
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park G, Choi J, Jang S, Jeong S, Kim C, Choi I
Ann Lab Med. 2015; 36(2):124-30.
PMID: 26709259
PMC: 4713845.
DOI: 10.3343/alm.2016.36.2.124.
Molecular epidemiology and characterization of multiple drug-resistant (MDR) clinical isolates of Acinetobacter baumannii.
El-Shazly S, Dashti A, Vali L, Bolaris M, Ibrahim A
Int J Infect Dis. 2015; 41:42-9.
PMID: 26518066
PMC: 4691561.
DOI: 10.1016/j.ijid.2015.10.016.
Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India.
Rynga D, Shariff M, Deb M
Ann Clin Microbiol Antimicrob. 2015; 14:40.
PMID: 26338039
PMC: 4559170.
DOI: 10.1186/s12941-015-0101-5.
In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam.
Le Minh V, Nhu N, Phat V, Thompson C, Lan N, Thieu Nga T
J Med Microbiol. 2015; 64(10):1162-1169.
PMID: 26297024
PMC: 4755130.
DOI: 10.1099/jmm.0.000137.
Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using bla(OXA-51-like) sequence based typing.
Rafei R, Pailhories H, Hamze M, Eveillard M, Mallat H, Dabboussi F
BMC Microbiol. 2015; 15:103.
PMID: 25976451
PMC: 4432822.
DOI: 10.1186/s12866-015-0441-5.
The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model.
Henry R, Crane B, Powell D, Deveson Lucas D, Li Z, Aranda J
J Antimicrob Chemother. 2015; 70(5):1303-13.
PMID: 25587995
PMC: 4398468.
DOI: 10.1093/jac/dku536.
Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii.
Beceiro A, Moreno A, Fernandez N, Vallejo J, Aranda J, Adler B
Antimicrob Agents Chemother. 2013; 58(1):518-26.
PMID: 24189257
PMC: 3910726.
DOI: 10.1128/AAC.01597-13.
Rapid determination of colistin resistance in clinical strains of Acinetobacter baumannii by use of the micromax assay.
Tamayo M, Santiso R, Otero F, Bou G, Lepe J, McConnell M
J Clin Microbiol. 2013; 51(11):3675-82.
PMID: 23985913
PMC: 3889750.
DOI: 10.1128/JCM.01787-13.
The clinical characteristics, carbapenem resistance, and outcome of Acinetobacter bacteremia according to genospecies.
Park K, Shin J, Lee S, Kim S, Jang M, Kang S
PLoS One. 2013; 8(6):e65026.
PMID: 23755171
PMC: 3670905.
DOI: 10.1371/journal.pone.0065026.
Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/pharmacodynamic model.
Lee H, Bergen P, Bulitta J, Tsuji B, Forrest A, Nation R
Antimicrob Agents Chemother. 2013; 57(8):3738-45.
PMID: 23716052
PMC: 3719722.
DOI: 10.1128/AAC.00703-13.
Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes.
Lin L, Tan B, Pantapalangkoor P, Ho T, Hujer A, Taracila M
Vaccine. 2012; 31(2):313-8.
PMID: 23153442
PMC: 3557524.
DOI: 10.1016/j.vaccine.2012.11.008.
Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis.
Lin L, Tan B, Pantapalangkoor P, Ho T, Baquir B, Tomaras A
mBio. 2012; 3(5).
PMID: 23033474
PMC: 3518917.
DOI: 10.1128/mBio.00312-12.